Structure of HIV-1 Reverse Transcriptase with the Inhibitor β-Thujaplicinol Bound at the RNase H Active Site
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Summary Novel inhibitors are needed to counteract the rapid emergence of drug-resistant HIV variants. HIV-1 reverse transcriptase (RT) has both DNA polymerase and RNase H (RNH) enzymatic activities, but approved drugs that inhibit RT target the polymerase. Inhibitors that act against new targets, like RNH, would be effective against all of the current drug-resistant variants. Here, we present 2.80 Å and 2.04 Å resolution crystal structures of an RNH inhibitor, β-thujaplicinol, bound at the RNH active site of both HIV-1 RT and an isolated RNH domain. β-thujaplicinol chelates two divalent metal ions at the RNH active site. We provide biochemical evidence that β-thujaplicinol is a slow-binding RNH inhibitor with non-competitive kinetics and suggest that it forms a tropylium ion that interacts favorably with RT and the RNA:DNA substrate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., & Steitz, T. A. (1992) · Science · doi:10.1126/science.1377403 · Cited by 1,914 · cited 2×
“In both subunits, these residues comprise the four polymerase subdomains: thumb, palm, fingers, and connection[3, 4].”
BackgroundA general two-metal-ion mechanism for catalytic RNA
Steitz, T. A., & Steitz, J. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6498 · Cited by 1,171 · cited 2×
“In the two-cation mechanism, Metal A helps to position the catalytic water for nucleophilic attack and Metal B stabilizes the pentacovalent transition state of reaction[28, 29].”
BackgroundJacobo-Molina, A., Ding, J., Nanni, R. G., Clark, A. D., Lu, X., Tantillo, C., Williams, R. L., Kamer, G., Ferris, A. L., Clark, P., et al. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6320 · Cited by 1,115
Self-citationNowotny, M., Gaidamakov, S. A., Crouch, R. J., & Yang, W. (2005) · Cell · doi:10.1016/j.cell.2005.04.024 · Cited by 620 · cited 1×
“halodurans RNase H/RNA:DNA[32] and human RNase H1/RNA:DNA[33], both with an active site point mutation to inactivate the enzyme, show the substrate bound to the active site in position appropriate for cleavage along with two cations, lending support to the two-cation mechanism.”
BackgroundCrystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase
Davies, J. F., Hostomska, Z., Hostomsky, Z., Jordan, S. R., & Matthews, D. A. (1991) · Science · doi:10.1126/science.1707186 · Cited by 570
Grobler, J. A., Stillmock, K., Hu, B., Witmer, M., Felock, P., Espeseth, A. S., Wolfe, A., Egbertson, M., Bourgeois, M., Melamed, J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092056199 · Cited by 399 · cited 3×
“The authors postulated that this RNHI has a metal ion-dependent inhibition mechanism that is similar to that of related HIV integrase inhibitors[11].”
BackgroundResultHow does RNase H recognize a DNA.RNA hybrid?
Nakamura, H., Oda, Y., Iwai, S., Inoue, H., Ohtsuka, E., Kanaya, S., Kimura, S., Katsuda, C., Katayanagi, K., & Morikawa, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11535 · Cited by 193
Role of histidine 124 in the catalytic function of ribonuclease HI from Escherichia coli
Oda, Y., Yoshida, M., & Kanaya, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54118-1 · Cited by 85 · cited 1×
“coli RNase HI, it has been suggested that His124 (RT His539) serves as the general base[23].”
BackgroundKanaya, S., Oobatake, M., & Liu, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32729 · Cited by 75
Research works printed but not linked: 42
- Bauman, 2008, Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design, Nucleic Acids Res., 36, 5083, 10.1093/nar/gkn464 · DOI · Paper page
- Beilhartz, 2009, HIV-1 reverse transcriptase can simultaneously engage its DNA/RNA substrate at both DNA polymerase and RNase H active sites: implications for RNase H inhibition, J. Mol. Biol., 388, 462, 10.1016/j.jmb.2009.03.025 · DOI · Paper page
- Brodsky, 2006, Economical parallel protein expression screening and scale-up in Escherichia coli, J. Struct. Funct. Genomics, 7, 101, 10.1007/s10969-006-9013-0 · doi:10.1007/s10969-006-9013-0
- Brünger, 1998, Crystallography and NMR system: a new software suite for macromolecular structure determination, Acta Crystallogr. D Biol. Crystallogr., 54, 905, 10.1107/S0907444998003254 · DOI · Paper page
- Budihas, 2005, Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones, Nucleic Acids Res., 33, 1249, 10.1093/nar/gki268 · DOI · Paper page
- Clark, 1995, Crystallization of human immunodeficiency virus type 1 reverse transcriptase with and without nucleic acid substrates, inhibitors and an antibody fab fragment, Methods Enzymol., 262, 171, 10.1016/0076-6879(95)62017-6 · DOI
- Cogan, 1976, Binding affinities of retinol and related compounds to retinol binding proteins, Eur. J. Biochem., 65, 71, 10.1111/j.1432-1033.1976.tb10390.x · DOI · Paper page
- Dewar, 1945, Structure of stipitatic acid, Nature, 155, 50, 10.1038/155050b0 · DOI · Paper page
- Ding, 1997, Protein-nucleic acid interactions and DNA conformation in a complex of human immunodeficiency virus type 1 reverse transcriptase with a double-stranded DNA template-primer, Biopolymers, 44, 125, 10.1002/(SICI)1097-0282(1997)44:2<125::AID-BIP2>3.0.CO;2-X · DOI
- Emsley, 2004, Coot: model-building tools for molecular graphics, Acta Crystallogr. D Biol. Crystallogr., 60, 2126, 10.1107/S0907444904019158 · DOI · Paper page
- Engh, 1991, Accurate bond and angle parameters for x-ray protein structure refinement, Acta Crystallogr. A, 47, 392, 10.1107/S0108767391001071 · DOI · Paper page
- Gardner, 1957, Occurrence of 2,7-dihydroxy-4-isopropyl-2,4,6-cycloheptatrien-1-one (7-hydroxy-4-iso-propyltropolone) in Western Red Cedar (Thuja plicata Donn.), Can. J. Chem., 35, 1039, 10.1139/v57-141 · doi:10.1139/v57-141
- Garvey, 2008, The Naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral, Antimicrob. Agents Chemother., 52, 901, 10.1128/AAC.01218-07 · DOI
- Goedken, 2001, Co-crystal of Escherichia coli RNase HI with Mn2+ ions reveals two divalent metals bound in the active site, J. Biol. Chem., 276, 7266, 10.1074/jbc.M009626200 · DOI · Paper page
- Hang, 2004, Activity of the isolated HIV RNase H domain and specific inhibition by N-hydroxyimides, Biochem. Biophys. Res. Commun., 317, 321, 10.1016/j.bbrc.2004.03.061 · DOI
- Himmel, 2006, HIV-1 reverse transcriptase structure with RNase H inhibitor dihydroxy benzoyl naphthyl hydrazone bound at a novel site, ACS Chem. Biol., 1, 702, 10.1021/cb600303y · DOI · Paper page
- Hsiou, 1996, Structure of unliganded HIV-1 reverse transcriptase at 2.7 Å resolution: implications of conformational changes for polymerization and inhibition mechanisms, Structure, 4, 853, 10.1016/S0969-2126(96)00091-3 · DOI · Paper page
- Huang, 1998, Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance, Science, 282, 1669, 10.1126/science.282.5394.1669 · DOI · Paper page
- Jones, 1991, Improved experimental procedures for building protein models in electron-density maps and the location of errors in these models, Acta Crystallogr. A, 47, 110, 10.1107/S0108767390010224 · DOI · Paper page
- Katayanagi, 1993, Crystal structure of Escherichia coli Rnase HI in complex with Mg2+ at 2.8 A resolution: proof for a single Mg(2+)-binding site, Proteins, 17, 337, 10.1002/prot.340170402 · DOI · Paper page
- Keck, 1998, Activation/attenuation model for RNase H: a one-metal mechanism with second-metal inhibition, J. Biol. Chem., 273, 34128, 10.1074/jbc.273.51.34128 · DOI · Paper page
- Kleywegt, 1996, Checking your imagination: applications of the free R value, Structure, 4, 897, 10.1016/S0969-2126(96)00097-4 · DOI · Paper page
- Kleywegt, 1994, Crystal structures of cellular retinoic acid binding proteins I and II in complex with all-trans-retinoic acid and a synthetic retinoid, Structure, 2, 1241, 10.1016/S0969-2126(94)00125-1 · DOI · Paper page
- Klumpp, 2006, Recent progress in the design of small molecule inhibitors of HIV RNase H, Curr. Pharm. Des., 12, 1909, 10.2174/138161206776873653 · DOI · Paper page
- Klumpp, 2003, Two-metal ion mechanism of RNA cleavage by HIV RNase H and mechanism-based design of selective HIV RNase H inhibitors, Nucleic Acids Res., 31, 6852, 10.1093/nar/gkg881 · DOI · Paper page
- Kolomnikova, 1967, Advances in the chemistry of the tropylium ion, Russ. Chem. Rev., 36, 735, 10.1070/RC1967v036n10ABEH001768 · doi:10.1070/rc1967v036n10abeh001768
- Krishnaswamy, 2005, Exosite-driven substrate specificity and function in coagulation, J. Thromb. Haemost., 3, 54, 10.1111/j.1538-7836.2004.01021.x · DOI
- Luzzati, 1952, Traitement statistique des erreurs dans la determination des structure cristallines, Acta Crystallogr., 5, 802, 10.1107/S0365110X52002161 · DOI · Paper page
- Murshudov, 1997, Refinement of macromolecular structures by the maximum-likelihood method, Acta Crystallogr. D Biol. Crystallogr., 53, 240, 10.1107/S0907444996012255 · DOI · Paper page
- Nowotny, 2007, Structure of Human RNase H1 complexed with an RNA/DNA hybrid: insight into HIV reverse transcription, Mol. Cell, 28, 264, 10.1016/j.molcel.2007.08.015 · DOI · Paper page
- Oda, 1991, Binding of metal ions to E. Coli RNase HI observed by 1H-15N heteronuclear 2D NMR, J. Biomol. NMR, 1, 247, 10.1007/BF01875518 · DOI
- Parniak, 2003, A fluorescence-based high-throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity, Anal. Biochem., 322, 33, 10.1016/j.ab.2003.06.001 · DOI
- Pauson, 1955, Tropones and tropolones, Chem. Rev., 55, 9, 10.1021/cr50001a002 · doi:10.1021/cr50001a002
- Pietra, 1973, Seven-membered conjugated carbo- and heterocyclic compounds and their homoconjugated analogs and metal complexes: synthesis, biosynthesis, structure, and reactivity, Chem. Rev., 73, 293, 10.1021/cr60284a002 · doi:10.1021/cr60284a002
- Read, 2001, Pushing the boundaries of molecular replacement with maximum likelihood, Acta Crystallogr. D Biol. Crystallogr., 57, 1373, 10.1107/S0907444901012471 · DOI · Paper page
- Richardson, 2006, Mechanism of Mos1 transposition: insights from structural analysis, EMBO J., 25, 1324, 10.1038/sj.emboj.7601018 · DOI
- Sarafianos, 2004, Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases, Curr. Opin. Struct. Biol., 14, 716, 10.1016/j.sbi.2004.10.013 · DOI
- Sarafianos, 2001, Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA, EMBO J., 20, 1449, 10.1093/emboj/20.6.1449 · DOI · Paper page
- Shaw-Reid, 2003, Inhibition of HIV-1 ribonuclease H by a novel diketo acid, 4-[5-(benzoylamino)thien-2-Yl]-2,4-dioxobutanoic acid, J. Biol. Chem., 278, 2777, 10.1074/jbc.C200621200 · DOI · Paper page
- Tisdale, 1991, Mutations within the RNase H domain of HIV-1 RT abolish virus infectivity, J. Gen. Virol., 72, 59, 10.1099/0022-1317-72-1-59 · DOI · Paper page
- Wittwer, 2007, Substrate-dependent inhibition kinetics of an active site-directed inhibitor of ADAMTS-4 (Aggrecanase 1), Biochem, 46, 6393, 10.1021/bi7000642 · DOI
- Yang, 1990, Structure of ribonuclease H phased at 2 A resolution by MAD analysis of the selenomethionyl protein, Science, 249, 1398, 10.1126/science.2169648 · DOI · Paper page
Cited by
Targeting Metalloenzymes for Therapeutic Intervention
Chen, A. Y., Adamek, R. N., Dick, B. L., Credille, C. V., Morrison, C. N., & Cohen, S. M. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00201 · Cited by 270
HIV-1 ribonuclease H: structure, catalytic mechanism and inhibitors
Beilhartz, G. L., & Götte, M. (2010) · Viruses · doi:10.3390/v2040900 · Cited by 88
“This model would likewise be in agreement with classical non-competitive kinetics measured under steadystate conditions [39,89,90].”
BackgroundResultInfluentialChung, S., Himmel, D. M., Jiang, J.-K., Wojtak, K., Bauman, J. D., Rausch, J. W., Wilson, J. A., Beutler, J. A., Thomas, C. J., Arnold, E., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2000757 · Cited by 80
Self-citationDas, K., Martinez, S. E., Bandwar, R. P., & Arnold, E. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku487 · Cited by 68
Self-citationLe Grice, S. F. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.389056 · Cited by 73
Metadata
- Authors
- Himmel, D. M., Maegley, K. A., Pauly, T. A., Bauman, J. D., Das, K., Dharia, C., Clark, A. D., Ryan, K., Hickey, M. J., Love, R. A., Hughes, S. H., Bergqvist, S., & Arnold, E.
- Venue
- Structure
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 17
- Issue
- 12
- Pages
- 1625-1635
- ISSN
- 0969-2126 (ISSN-L)
- OpenAlex
- W2063387690
- Cited by
- 140
- References
- 9
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1355 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.